STOCK TITAN

Organigram Global Inc Stock Price, News & Analysis

OGI Nasdaq

Welcome to our dedicated page for Organigram Global news (Ticker: OGI), a resource for investors and traders seeking the latest updates and insights on Organigram Global stock.

News about Organigram Global Inc. (NASDAQ: OGI, TSX: OGI) focuses on its activities as a Canadian cannabis cultivator, manufacturer and brand owner operating under the Cannabis Act and Cannabis Regulations. Company announcements highlight its position as Canada’s number one cannabis company by market share in the recreational segment, as well as developments across cultivation, product innovation, beverages and international expansion.

Investors and observers following OGI news will see regular updates on quarterly and annual financial results, including net revenue trends, adjusted gross margin, adjusted EBITDA and free cash flow, as reported in its earnings releases. These updates often discuss the impact of acquisitions such as Motif Labs Ltd. and Collective Project Limited on revenue growth, extraction capabilities and beverage market participation, along with commentary on cost efficiencies and synergy realization.

Organigram’s news flow also covers product and brand launches. Examples include new SHRED gummies formats, Big Bag O’ Buds strains, BOXHOT infused pre-rolls, Trailblazer blunts, Rizzlers vapes and the happly hemp-derived THC brand in the United States. The company highlights its use of FAST™ nanoemulsion technology in ingestible products and describes how these offerings are designed around consumer preferences, including mood-based formulations.

Another important theme in Organigram news is international and policy-related activity. Releases describe record international sales, progress toward EU-GMP certification for the Moncton facility, exclusive genetics agreements with Phylos Bioscience Inc., and polling and economic reports that position legal cannabis as a contributor to Canada’s GDP, jobs and innovation. Corporate governance and leadership updates, such as CEO succession plans and executive appointments, are also communicated through news releases. For a fuller picture of OGI’s evolving strategy and operations, readers can review this ongoing stream of company disclosures.

Rhea-AI Summary

Organigram Holdings Inc. (NASDAQ: OGI) announces the launch of festive cannabis offerings: Trailblazer Kushmas Stix and Edison Bytes Gingerbread Truffles. Both products will be available in select provinces for holiday gifting. The Kushmas Stix features a blend of kush cultivars in a 0.5 g pre-roll format, while the Gingerbread Truffles contain 5 mg THC each, sold in packs of two. CEO Greg Engel highlights the company’s commitment to creativity and exceptional customer experiences with these seasonal products aimed at adult consumers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.03%
Tags
none
-
Rhea-AI Summary

Organigram Holdings (NASDAQ: OGI) announced CEO Greg Engel's appointment to the Board of Directors of the Canadian Chamber of Commerce. This recognition highlights the cannabis industry's growing significance to Canada's economy, generating jobs and fostering business advocacy. Engel will serve on the Member Relations & Services Committee, aiming to represent the cannabis sector's interests and contribute to broader Canadian business issues. The Canadian Chamber of Commerce has been a pivotal organization since 1925, advocating for public policies that support economic growth across the country.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.64%
Tags
management

FAQ

What is the current stock price of Organigram Global (OGI)?

The current stock price of Organigram Global (OGI) is $1.38 as of March 25, 2026.

What is the market cap of Organigram Global (OGI)?

The market cap of Organigram Global (OGI) is approximately 182.7M.

OGI Rankings

OGI Stock Data

182.69M
95.69M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Toronto

OGI RSS Feed